SCHEMBL17212261

SCHEMBL17212261

CC(=O)c1ccc(O)c(-n2nc3ccccc3n2)c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.43
RAB9A P51151 4/20 0.43
LMNA P02545 1/20 0.43
MAPT P10636 3/20 0.39
KDM4E B2RXH2 2/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 1/20 0.39
NSD2 O96028 1/20 0.39
KMT2A Q03164 1/20 0.39
MCL1 Q07820 1/20 0.39
HPGD P15428 2/20 0.39
SMN1; SMN2 Q16637 3/20 0.37
ALDH1A1 P00352 3/20 0.37
PARP1 P09874 1/20 0.36
HTT P42858 1/20 0.36
PPARG P37231 1/20 0.35
PPARA Q07869 1/20 0.35
TDP1 Q9NUW8 2/20 0.35
L3MBTL1 Q9Y468 2/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2553971 0.79 NPC1 (0.48) NPC1RAB9ALMNAMAPTKDM4E
SCHEMBL5846684 0.76 NPC1 (0.44) NPC1RAB9ALMNAKDM4EPOLB
SCHEMBL2472876 0.75 NPC1 (0.53) NPC1RAB9ALMNAMAPTKDM4E
SCHEMBL2474061 0.72 RAB9A (0.49) NPC1RAB9ALMNAMAPTKDM4E
SCHEMBL5330792 0.72 KDM4E (0.54) NPC1RAB9ALMNAMAPTKDM4E
SCHEMBL28515215 0.71 NPC1 (0.53) NPC1RAB9ALMNAKDM4EPOLB
SCHEMBL12196763 0.71 KDM4E (0.52) NPC1RAB9ALMNAMAPTKDM4E
SCHEMBL14462703 0.70 NPC1 (0.51) NPC1RAB9ALMNAKDM4EPOLB
SCHEMBL673476 0.70 NPC1 (0.38) NPC1RAB9ALMNAKDM4EMCL1
SCHEMBL1263238 0.70 NPC1 (0.62) NPC1RAB9ALMNAMAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150306002-A1 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES MERCK PATENT GMBH (DE) 2015-10-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150306002-A1 3-HYDROXY-4-OXO-4H-PYRAN- OR 3-HYDROXY-4-OXO-1,4-DIHYDROPYRIDINE DERIVATIVES AS PROTEIN-ADHESIVE ACTIVE SUBSTANCES S100A4, CUTA, OCIAD1 NPC1 4778/4885RAB9A 3349/4885LMNA 1889/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.